Evidence map›Paper›PMID 28496915›Full record

ReviewJournal of atrial fibrillation2013

Atrial Fibrillation and Stroke - Increasing Stroke Risk With Intervention.

Christopher V DeSimone, Elisa Madhavan, Sébastien Ebrille, Alejandro A Rabinstein, Paul A Friedman, Samuel J Asirvatham

Abstract readReview
In one paragraph

Review in Journal of atrial fibrillation, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Christopher V DeSimoneDivision of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
Elisa MadhavanDivision of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
Sébastien EbrilleDepartment of Cardiology, University of Turin, Italy.
Alejandro A RabinsteinDepart of Neurology, Mayo Clinic, Rochester, MN.
Paul A FriedmanDivision of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.
Samuel J AsirvathamDivision of Cardiovascular Diseases, Mayo Clinic, Rochester, MN.

Funding

CARDIOVASOLOGYT32HL007111 · NHLBI · MAYO CLINIC ROCHESTER · PI Barry A. Borlaug · 1985 to 2026
$8.7M
NHLBI NIH HHS T32 HL007111
6 · The paper itself

Abstract

In this review, we focus on the important newly recognized appreciation for the paradoxical increase in stroke and TIA as a result of intervention meant to treat atrial fibrillation (AF) with the hope of decreasing stroke risk in the long term. The impact of silent cerebral lesions recently appreciated as a potentially major limitation and risk with AF ablation is explained. We categorize our present understanding of how we can minimize risk and provide a platform for what will undoubtedly be newer study, changes in the way procedures are done today, and possibly vascular-based stroke-reduction strategies.

Indexed as

AblationAtrial FibrillationCatheterEmbolismSilent Cerebral Lesions

Identifiers

PMID28496915
PMCPMC4829953

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.